Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC)

Clinical trial NCT03084380 · UNKNOWN

Trial details

NCT number: NCT03084380
Sponsor: Xinqiao Hospital of Chongqing
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2017-06-01
Primary completion: 2019-05-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.